Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited’s Net Profit Dropped 29.5% in 2024

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (广州白云山医药集团股份有限公司) (600332.SH) reported a net profit of 3 billion yuan in 2024, down 29.5% year-on-year.

Meanwhile, the company posted 75 billion yuan in revenue, down 0.7% year-on-year.

At the end of the reporting period, it had 81.7 billion yuan in total assets and 43.9 billion yuan in total liabilities, with a liability-to-asset ratio of 53.8%.